Entrapment / Compressive Mononeuropathies Conservative: wrist splinting (CTS), activity modification, NSAIDs, corticosteroid injection (CPT 20526 CTS injection) Surgical decompression: carpal tunnel release (CPT 64721), cubital tunnel decompression/transposition (CPT 64718), tarsal tunnel release (CPT 28035), peroneal nerve decompression Post-surgical documentation: note surgical findings, nerve condition, expected recovery timeline Diabetic Neuropathy Glycemic optimization (primary modifier for progression)
GLOW Blend peptide dosage depends on the prescribed treatment plan, peptide concentration, and individual wellness goals
All use must remain within research-only boundaries - neither compound is approved by the FDA or EMA, BPC-157 was placed on the FDA 503A Category 2 list in 2023, and TB-500 is on the WADA Prohibited List under class S2
administer IM, may be administered subcut or IV at the discretion of a veterinarian